Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Vectra DA
Usual Care
Locations
40
United States
Rheumatology Associates of North Alabama PC
Huntsville, Alabama, United States
Dana Copeland Redyy Rheumatology
Chula Vista, California, United States
Medvin Clinical Research
Covina, California, United States
Western Connecticut Health Network
Danbury, Connecticut, United States
Delaware Arthritis
Lewes, Delaware, United States
Howard University
Washington D.C., District of Columbia, United States
Start Date
June 1, 2016
Primary Completion Date
August 1, 2022
Completion Date
August 1, 2022
Last Updated
July 30, 2018
NCT07017686
NCT05038553
NCT05790356
NCT03429426
NCT06028438
NCT06800157
Lead Sponsor
Crescendo Bioscience
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions